Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon
doi: https://doi.org/10.1101/2021.08.24.21262415

Article Information

doi 
https://doi.org/10.1101/2021.08.24.21262415
History 
  • August 25, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sivan Gazit, MD MA1,2,*,
  2. Roei Shlezinger, BA1,
  3. Galit Perez, MN MA2,
  4. Roni Lotan, PhD2,
  5. Asaf Peretz, MD1,3,
  6. Amir Ben-Tov, MD1,4,
  7. Dani Cohen, PhD4,
  8. Khitam Muhsen, PhD4,
  9. Gabriel Chodick, PhD MHA2,4 and
  10. Tal Patalon, MD1,2
  1. 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, 68125, Israel
  2. 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Israel
  3. 3Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod Israel
  4. 4Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel
  1. ↵*Corresponding author: Sivan Gazit, gazit_s{at}mac.org.il, 27 HaMared street, Tel Aviv, 68125, Israel
Back to top
Posted August 25, 2021.
Download PDF
Data/Code
Email
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon
medRxiv 2021.08.24.21262415; doi: https://doi.org/10.1101/2021.08.24.21262415
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area